6/25 EVENT PANELIST

Douglas Brooks

Sunny Hostin

Executive Director, Community Engagement, Gilead Sciences, Inc.
He/Him/His

Douglas M. Brooks, a social worker, began his career in HIV/AIDS with his work for the Provincetown AIDS Support Group. He went on to become the Senior Vice President for Community, Health, and Public Policy at the Justice Resource Institute (JRI), a regional health and human service agency based in Massachusetts. He also previously served as Executive Director of the Sidney Borum Jr. Health Center in Boston.

Brooks served as Chair of the Board of Trustees of AIDS United in Washington, DC. In 2010, he was appointed to The Presidential Advisory Council on HIV/AIDS (PACHA) and subsequently named that body’s liaison to the CDC/HRSA Advisory Committee (CHAC). In 2014, he was appointed to be Director of the White House Office of National AIDS Policy.

In 2015, Douglas spearheaded an update to the National HIV/AIDS Strategy, a five- year plan to guide priorities and principles for the nation’s response to HIV. Douglas is an openly gay man living with HIV. During his time as director of ONAP, he focused on turning attention to populations most affected by the epidemic—including gay and bisexual men of all races and ethnicities, notably those who are Black and LatinX, Black women, transgender men and women, and people living in the Southern U.S. He supported the widespread scale-up of PrEP, and included this in the updated strategy as a key way to reduce new infections in the U.S.

Douglas holds a BS from Lesley University, a MSW from Boston University and an Honorary Doctorate from Fordham University.

In May of 2016, Douglas started in the newly created role of Senior Director for Community Engagement at Gilead Sciences. He is currently Executive Director for Community Engagement at Gilead and serves on the board of directors for the San Francisco AIDS Foundation and is on the Advisory Board for the Center for Innovation in Social Work and Health at Boston University.

Gilead Website

This campaign is made possible through a grant from Gilead Sciences, Inc.